BRCA2 and breast carcinoma: The effects on these subgroups are subtle, contrary to mutations such as in breast cancer type 1 (BRCA1) & breast cancer type 2 (BRCA2) that, when present, predict an approximate 70% chance of the development of breast cancer by the age of 80 [25].